Water for Injection (WFI) System Validation in Pharmaceuticals | A Complete Guide of WFI System

Water used as a raw material in pharmaceutical manufacturing industry. There are different grades of water used in pharmaceuticals but Water for Injection (WFI) is the highest quality water used in preparing the injectable drugs, cleaning equipment and manufacturing other sterile products. The validation of WFI system is a fundamental requirement of regulatory agencies because it directly impacts the product quality and patient safety.
This post provides in-depth knowledge of WFI system validation covering the regulatory expectations, validation stages and best practices.

Introduction to WFI

Water for injection is highly purified water that must meet the microbiological and chemical quality standards.
Unlike purified water, WFI must comply with additional test requirements.
Microbial count: Not more than 10 CFU/100 ml
Endotoxins: NMT 0.25 EU/ml
Conductivity & TOC: Must meet USP <645> and <643> standards.

In pharmaceutical manufacturing, WFI is produced by multi column distillation process but European Pharmacopoeia (EP) now allows prepare WFI using reverse osmosis and ultrafiltration if validation proves its equivalence with traditional method.

Why Validate WFI Systems?

WFI system validation ensures that it produces water of required quality consistently. Without validation microbial contamination may lead to product recalls, endotoxin presence may cause pyrogenic reactions in patients and regulatory noncompliance may result in warning letters and plant shutdowns.

Regulatory Requirements for WFI System Validation

Different regulatory agencies have defined their expectations for WFI systems.

• FDA (21 CFR 211.113 & 211.160): Requires control of microbial contamination and proper monitoring of WFI systems.
• USP (United States Pharmacopeia): Defines analytical and microbiological limits for WFI used in pharmaceuticals.
• EMA / EU GMP Annex 1: Allows both distillation and membrane processes for WFI preparation, with strict control and monitoring of system.
• WHO TRS 970: Stresses WFI system design, sanitization, and monitoring as part of validation.

Design qualification, performance qualification and ongoing monitoring of water for injection system are the common requirements of all the regulatory agencies.

Stages of WFI System Validation

V-model approach is followed in WFI system validation ensuring all phases are documented and traceable.

Stage 1: User Requirement Specification (URS)

It defines what the company needs from the WFI system including capacity, quality and compliance expectations.

Stage 2: Design Qualification (DQ)

Design qualification ensures the selected design meets the URS and GMP requirements. It helps to understand the piping design, loop configuration and sanitization methods used in WFI system.

Stage 3: Installation Qualification (IQ)

Installation qualification verifies that system is installed as per approved design including equipment checks piping material certificates, instrument calibration and documentation.

Stage 4: Operational Qualification (OQ)

Operational qualification confirms that system operates within defined parameters that involve the testing of alarms, control systems, sanitization cycles and operating range.

Stage 5: Performance Qualification (PQ)

Performance qualification is the most important stage of WFI system validation where WFI quality is verified over an extended period of time. PQ of WFI system is done in three phases.
1. Phase I (2–4 weeks): Daily sampling and monitoring of microbial count, endotoxins, TOC, and conductivity are done in this phase.
2. Phase II (4–6 weeks): Reduced sampling like every alternate day is done in this phase to demonstrate consistency of WFI quality.
3. Phase III (1 year): Routine monitoring under normal operating conditions is done for one year to confirm long-term reliability.
Related: Reverse Osmosis System for Water Purification

Acceptance Criteria

1. The system is installed in accordance with design specifications, manufacturer recommendations, and cGMPs. Instruments are calibrated, identified, and entered into the calibration program.
2. General controls and alarms operate in accordance with the design specification.
3. The system operates in accordance with design specifications throughout the operating range or range of intended use.
4. The system flow rate must be in compliance with design specifications.
5. All samples must meet the following criteria:
a. Chemical Testing: Test samples must meet the acceptance criteria of the chemical tests as described in USP Monograph on Water for Injection.
b. Bacteriological Purity: All samples must contain no more than 10 cfu/100 ml; no pseudomonas or coliform is detected.
c. Endotoxins: All samples must contain no more than 0.25 EU/ml.
d. Physical Properties: The temperature of the hot Water for Injection must be greater than 80°C.
e. Particulate Matter: Small Volume Injection: The Small Volume Injection meets the requirements of the test if the average number of particles it contains is not more than 10,000 per container that is equal to or greater than 10 µm in effective spherical diameter and not more than 1000 per container equal to or greater than 25 µm in effective spherical diameter.
Related: Water for Injection System Validation Protocol

Common Challenges in WFI System Validation

• Biofilm formation is the most common problem in water systems. It is very difficult to eliminate biofilms from pharmaceutical water systems. Preventive design and sanitization are key steps to eliminate the problem of biofilm formation.
• Poor piping designs and dead legs are other issues that can lead to stagnant water and microbial growth. FDA and WHO recommend dead legs less than 1.5 the pipe diameter.
• Improper sanitation due to failure to maintain sanitization frequency can cause microbial growth and biofilm formation in water system.

Related: Removal of Pathogenic Bacteria from Water Systems

Best Practices for WFI System Validation

• Keep design with the GMP in mind. Use sanitary piping, orbital welding and slope to drain designs. Avoid dead ends and stagnant points.
• Maintain validation protocols, SOPs and reports for every validation stage and document deviation and corrective actions properly.
• Daily monitor water system during PQ for routine checks for microbial contamination, endotoxin, TOC and conductivity tests.
• Regularly calibrate instruments and sanitize whole system as per schedule.
• Prepare trend and review data to track results overtime and identify early warning signals before any problem occurs.

Revalidation of WFI Systems

As we have discussed in many articles, validation is not a one-time activity but it is required when any major system modification occurs, like new loop extension, replacement of any major equipment, any unexplained quality excursion observed or after prolonged system shutdowns. In normal conditions WFI systems undergo a periodic review and revalidation in every one to three years depending on risk assessment.

Water for injection (WFI) is the backbone of injectable pharmaceutical manufacturing. Compromised quality can pose severe risk to patients using drug products because WFI is directly used in products. Regulatory agencies like FDA, EMA and WHO require proper design, validation and ongoing monitoring of WFI systems.

A validated WFI system that has proper documentation, preventive maintenance and continuous monitoring ensures compliance and also builds trust in product quality and patient safety.

Get ready to use editable Validation Protocols in MS-Word FormatView List

Share

Tweet

Share

Pin it

Share